Categories AlphaGraphs, Earnings, Health Care
AbbVie shares gain after Q3 results beat estimates: Infographic
AbbVie (NYSE: ABBV) reported third-quarter 2020 financial results before the regular trading hours on Friday. The pharmaceutical behemoth reported Q3 revenue of $12.9 billion, which surpassed the Wall Street consensus. Net earnings of $2.83 per share were also better than the target that analysts had projected.
ABBV shares gained 1.4% immediately following the announcement. The stock has slipped 10% since the beginning of this year.
AbbVie’s flagship arthritis drug Humira reported net revenues of $5.140 billion, which was 4% more than last year. While sales increased 7.7% in the US, international markets saw a 9% decrease due to competition from biosimilars.
Prior performance
Most Popular
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
Target (TGT): A look at some of the challenges faced by the retailer in 3Q24
Shares of Target Corporation (NYSE: TGT) stayed green on Thursday, recovering from the stumble it took a day ago after delivering disappointing results for the third quarter of 2024 and